Search
Patexia Research
Case number 2018-1740

Momenta Pharmaceuticals, Inc. v. Amphastar Pharmaceuticals, Inc > Documents

Date Field Doc. No.Description (Pages)
Jun 26, 2019 77 ORDER filed. The motion [76] is granted. The stay of the briefing schedule is lifted, and the appeal is dismissed. Each side shall bear its own costs. ISSUED AS A MANDATE: June 26, 2019. Service: 06/26/2019 by clerk. [616995] [NL] [Entered: 06/26/2019 10:33 AM] (2)
Jun 19, 2019 76 MOTION of Appellants Momenta Pharmaceuticals, Inc., Sandoz Inc. and Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd. to voluntarily dismiss appeal pursuant to FRAP 42(b). [Consent: unopposed]. Service: 06/19/2019 by email. [615646] [18-1740] [Deanne Maynard] [Entered: 06/19/2019 04:24 PM] (10)
Jun 17, 2019 75 ORDER filed. The motion for a limited remand [72] is granted to the limited extent explained in the order. This court retains jurisdiction over this appeal. The motion for a stay [58] is granted to the extent that the briefing schedule is stayed pending the district court's decision on the parties' request for vacatur. The parties are directed to inform the court within 30 days of the district court's decision on the request for vacatur as to how they believe this appeal should proceed. Service: 06/17/2019 by clerk. [614808] [LMS] [Entered: 06/17/2019 03:48 PM] (3)
Jun 14, 2019 74 **TEXT ONLY** ORDER granting motion to withdraw attorney Michael Qian [73] filed by Appellants Sandoz Inc. and Momenta Pharmaceuticals, Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [614345] [MMA] [Entered: 06/14/2019 02:38 PM] (0)
Jun 13, 2019 73 MOTION of Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc. to withdraw counsel Michael F. Qian [Consent: unopposed]. Service: 06/13/2019 by email. [613967] [18-1740] [Michael Qian] [Entered: 06/13/2019 02:22 PM] (6)
May 23, 2019 72 MOTION of Appellees Amphastar Pharmaceuticals, Inc., International Medication Systems, Ltd. and Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc. for limited remand [Consent: unopposed]. Service: 05/23/2019 by email. [609461] [18-1740] [Deanne Maynard] [Entered: 05/23/2019 10:15 PM] (16)
May 23, 2019 71 ORDER filed. The motion for an extension of time [70] is granted. Service: 05/23/2019 by clerk. [609331] [LMS] [Entered: 05/23/2019 12:19 PM] (2)
May 21, 2019 70 MOTION of Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd. to extend the time to 06/27/2019 to file Response/Reply. Any response is due within 10 days of service [Consent: unopposed]. Service: 05/21/2019 by email. [608657] [18-1740] [Joshua Mack] [Entered: 05/21/2019 12:31 PM] (11)
Apr 19, 2019 68 ORDER filed. The motion [67] for an extension of time is granted. Service: 04/19/2019 by clerk. [601726] [NL] [Entered: 04/19/2019 04:23 PM] (2)
Apr 18, 2019 67 MOTION of Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd. to extend the time to 05/28/2019 to file Response/Reply. Any response is due within 10 days of service [Consent: unopposed]. Service: 04/18/2019 by email. [601261] [18-1740] [Joshua Mack] [Entered: 04/18/2019 12:35 PM] (11)
Apr 8, 2019 66 ORDER filed. The motion for an extension of time [65] is granted. Service: 04/08/2019 by clerk. [598397] [LMS] [Entered: 04/08/2019 11:12 AM] (2)
Apr 4, 2019 65 MOTION of Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd. to extend the time to 04/25/2019 to file Response/Reply. Any response is due within 10 days of service [Consent: unopposed]. Service: 04/04/2019 by email. [597838] [18-1740] [Joshua Mack] [Entered: 04/04/2019 12:49 PM] (11)
Mar 20, 2019 64 ORDER filed. The motion for an extension of time [63] is granted. Service: 03/20/2019 by clerk. [594216] [LMS] [Entered: 03/20/2019 01:15 PM] (2)
Mar 19, 2019 63 MOTION of Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd. to extend the time to 04/11/2019 to file Response/Reply. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/19/2019 by email. [594045] [18-1740] [Joshua Mack] [Entered: 03/19/2019 07:16 PM] (11)
Mar 5, 2019 62 ORDER filed. The motion for an extension of time [61] is granted. Service: 03/05/2019 by clerk. [590224] [LMS] [Entered: 03/05/2019 07:22 AM] (2)
Mar 4, 2019 61 MOTION of Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd. to extend the time to 03/21/2019 to file Response/Reply. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/04/2019 by email. [590112] [18-1740] [Joshua Mack] [Entered: 03/04/2019 02:55 PM] (9)
Mar 1, 2019 60 Amended Certificate of Interest for the Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. Service: 03/01/2019 by email. [589560] [18-1740] [Deanne Maynard] [Entered: 03/01/2019 10:02 AM] (3)
Feb 28, 2019 59 Sealed or confidential document received [Plaintiffs-Appellants' Confidential Motion to Stay the Appeal] (corresponding to Doc No. [58]) for Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. Service: 02/28/2019 by email. [589413] [18-1740] [Deanne Maynard] [Entered: 02/28/2019 01:28 PM] (0)
Feb 28, 2019 58 MOTION of Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc. to stay appeal [Consent: opposed]. Service: 02/28/2019 by email. [589407] [18-1740] [Deanne Maynard] [Entered: 02/28/2019 01:23 PM] (23)
Dec 10, 2018 57 Notice from Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc. regarding conflicts with oral argument. Service: 12/10/2018 by email. [570557] [18-1740]--[Edited 12/10/2018 by MJL to add party filer] [Deanne Maynard] [Entered: 12/10/2018 03:15 PM] (2)
Dec 10, 2018 56 Notice from Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd. regarding conflicts with oral argument. Service: 12/10/2018 by email. [570484] [18-1740] [Douglas Carsten] [Entered: 12/10/2018 01:00 PM] (2)
Dec 6, 2018 55 6 paper copies of the Confidential Joint Appendix Brief (Vol. I - IV) [47] received from Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. [570212] [CJF] [Entered: 12/07/2018 01:18 PM] (0)
Dec 3, 2018 54 Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [569186] [SJ] [Entered: 12/03/2018 11:11 AM] (0)
Dec 3, 2018 53 Notice to Advise of Scheduling Conflicts. Please advise of any scheduling conflicts during the upcoming court session months listed in the attached Notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [569184] [SJ] [Entered: 12/03/2018 11:08 AM] (1)
Nov 27, 2018 52 6 paper copies of the Reply Brief [46] received from Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. [567846] [CJF] [Entered: 11/27/2018 12:27 PM] (0)
Nov 26, 2018 51 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd.. Service: 11/26/2018 by email. [567671] [18-1740] [Michael Sommer] [Entered: 11/26/2018 11:36 PM] (3)
Nov 26, 2018 50 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. Service: 11/26/2018 by email. [567662] [18-1740] [Deanne Maynard] [Entered: 11/26/2018 08:08 PM] (3)
Nov 26, 2018 49 Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants Momenta Pharmaceuticals, Inc., Sandoz Inc. and Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd.. Service: 11/26/2018 by email. [567659] [18-1740] [Deanne Maynard] [Entered: 11/26/2018 08:05 PM] (3)
Nov 26, 2018 48 APPENDIX FILED (4 vols.) for Momenta Pharmaceuticals, Inc. and Sandoz Inc. Number of Pages: 2020. Service: 11/26/2018 by email. [567655] --[compliance review complete 12/03/2018 by SMJ] [Deanne Maynard] [Entered: 11/26/2018 08:02 PM] (2029)
Nov 26, 2018 47 CONFIDENTIAL JOINT APPENDIX FILED (4 vols.) for Momenta Pharmaceuticals, Inc. and Sandoz Inc. Number of Pages: 2020. Service: 11/26/2018 by email. [567652]--[compliance review complete 12/03/2018 by SMJ] [Deanne Maynard] [Entered: 11/26/2018 07:57 PM] (0)
Nov 19, 2018 46 REPLY BRIEF FILED for Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc. [45]. Number of Pages: 34. Service: 11/19/2018 by email. The paper copies of the brief should be received by the court on or before 12/03/2018. Appendix is due 11/26/2018. [567471]--[Edited 11/26/2018 by SMJ to correct file date] [SJ] [Entered: 11/26/2018 01:54 PM] (44)
Nov 19, 2018 45 TENDERED from Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. Title: REPLY BRIEF. Service: 11/19/2018 by email. [566287] [18-1740] [Deanne Maynard] [Entered: 11/19/2018 01:07 PM] (44)
Nov 2, 2018 44 ORDER filed. The motion [41] is granted. Service: 11/02/2018 by clerk. [562158] [NL] [Entered: 11/02/2018 10:48 AM] (2)
Oct 31, 2018 43 REPLY of Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc. to response filed by Appellees, Doc. No [42]. Service: 10/31/2018 by email. [561624] [18-1740] [Deanne Maynard] [Entered: 10/31/2018 12:39 PM] (10)
Oct 30, 2018 42 RESPONSE of Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd. to the motion [41] filed by Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. Service: 10/30/2018 by email. [561454] [18-1740] [Michael Sommer] [Entered: 10/30/2018 04:35 PM] (26)
Oct 29, 2018 41 MOTION of Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc. to extend the time to 11/19/2018 to file the Reply Brief currently due 11/05/2018.. [Consent: opposed]. Service: 10/29/2018 by email. [560935] [18-1740] [Deanne Maynard] [Entered: 10/29/2018 01:34 PM] (10)
Oct 9, 2018 40 Entry of appearance for Michael F. Qian as of counsel for Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. Service: 10/09/2018 by email. [555482] [18-1740] [Michael Qian] [Entered: 10/09/2018 09:54 AM] (2)
Oct 1, 2018 38 6 paper copies of the Opening Response Brief [36] received from Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd.. [553847] [CJF] [Entered: 10/01/2018 04:25 PM] (0)
Oct 1, 2018 39 ORDER filed. The motion [34] is granted. Momenta’s reply brief is due no later than November 5, 2018. Service: 10/01/2018 by clerk. [553890] [NL] [Entered: 10/01/2018 05:27 PM] (2)
Sep 28, 2018 37 REPLY of Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc. to response filed by Appellees, Doc. No [35]. Service: 09/28/2018 by email. [553280] [18-1740] [Deanne Maynard] [Entered: 09/28/2018 12:04 PM] (8)
Sep 27, 2018 35 RESPONSE of Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd. to the motion to extend time to file brief [34] filed by Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. Service: 09/27/2018 by email. [553138] [18-1740] [Michael Sommer] [Entered: 09/27/2018 09:12 PM] (33)
Sep 27, 2018 34 MOTION of Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc. to extend the time to 11/05/2018 to file the Reply Brief currently due 10/05/2018. [Consent: partial consent]. Service: 09/27/2018 by email. [552921] [18-1740] [Deanne Maynard] [Entered: 09/27/2018 09:38 AM] (9)
Sep 21, 2018 36 BRIEF FILED for Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd. [33]. Number of Pages: 64. Service: 09/21/2018 by email. The paper copies of the brief should be received by the court on or before 10/05/2018. Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc. reply brief is due 10/05/2018. [553271] [SJ] [Entered: 09/28/2018 11:53 AM] (79)
Sep 21, 2018 33 TENDERED from Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd.. Title: RESPONSE BRIEF. Service: 09/21/2018 by email. [551889] [18-1740] [Michael Sommer] [Entered: 09/21/2018 07:35 PM] (79)
Aug 16, 2018 32 **TEXT ONLY** ORDER granting motion to extend time to file brief [31] filed by Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd.. Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd. brief is due by 10/10/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [543459] [CMP] [Entered: 08/16/2018 03:20 PM] (0)
Aug 14, 2018 31 MOTION of Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd. to extend the time to 10/10/2018 to file the Defendants-Appellees' Initial Brief. [Consent: unopposed]. Service: 08/14/2018 by email. [542739] [18-1740] [Michael Sommer] [Entered: 08/14/2018 01:10 PM] (8)
Aug 14, 2018 30 **TEXT ONLY** ORDER granting motion to withdraw attorney Sophia M. Brill [29] filed by Appellants Sandoz Inc. and Momenta Pharmaceuticals, Inc.. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [542707] [CMP] [Entered: 08/14/2018 11:32 AM] (0)
Aug 10, 2018 29 MOTION of Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc. to withdraw counsel Sophia M. Brill [Consent: unopposed]. Service: 08/10/2018 by email. [542246] [18-1740] [Sophia Brill] [Entered: 08/10/2018 05:35 PM] (5)
Aug 3, 2018 28 6 paper copies of the Opening Brief [27] received from Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. [540672] [CJF] [Entered: 08/03/2018 12:21 PM] (0)
Jul 30, 2018 27 BRIEF FILED for Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc. [26]. Number of Pages: 72. Service: 07/30/2018 by email. The paper copies of the brief should be received by the court on or before 08/08/2018. Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd. brief is due 09/10/2018. [540242] [CMP] [Entered: 08/01/2018 04:19 PM] (170)
Jul 30, 2018 26 TENDERED from Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. Title: OPENING BRIEF. Service: 07/30/2018 by email. [539515] [18-1740] [Deanne Maynard] [Entered: 07/30/2018 05:31 PM] (170)
Jul 24, 2018 25 Amended Certificate of Interest for the Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. Service: 07/24/2018 by email. [538325] [18-1740] [Deanne Maynard] [Entered: 07/24/2018 06:19 PM] (3)
Jun 14, 2018 24 **TEXT ONLY** ORDER granting motion to extend time to file brief [23] filed by Appellants Sandoz Inc. and Momenta Pharmaceuticals, Inc. Brief due 07/30/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [529435] [CFT] [Entered: 06/14/2018 01:57 PM] (0)
Jun 14, 2018 23 MOTION of Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc. to extend the time to 07/30/2018 to file the Opening Brief. [Consent: unopposed]. Service: 06/14/2018 by email. [529380] [18-1740] [Deanne Maynard] [Entered: 06/14/2018 11:55 AM] (9)
May 18, 2018 22 **TEXT ONLY** ORDER granting motion to extend time to file brief [21] filed by Appellants Sandoz Inc. and Momenta Pharmaceuticals, Inc.. Brief is due 06/28/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [523008] [CMP] [Entered: 05/18/2018 04:22 PM] (0)
May 18, 2018 21 MOTION of Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc. to extend the time to 05/18/2018 to file the opening brief. [Consent: unopposed]. Service: 05/18/2018 by email. [522813] [18-1740] [Deanne Maynard] [Entered: 05/18/2018 11:44 AM] (9)
May 9, 2018 20 REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [520286] [CMP] [Entered: 05/09/2018 11:09 AM] (0)
Apr 13, 2018 19 Corrected Certificate of Interest for the Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd.. Service: 04/13/2018 by email. [513272] [18-1740] [Michael Sommer] [Entered: 04/13/2018 01:00 PM] (5)
Apr 13, 2018 18 NOTICE OF DEFICIENCY: The certificate of interest Document No. [6] filed by Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd. in 18-1740 is incomplete and therefore cannot be accepted for filing at this time. [CLERK'S NOTE: (1) Statement #2 regarding name of real party in interest was not completed. Use "none" if applicable. (2) Statement #5 regarding related cases was not included. A current Certificate of Interest form is available on the court's website.] You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [513155] [CAB] [Entered: 04/13/2018 10:04 AM] (0)
Apr 12, 2018 17 Entry of appearance for Erik J. Olson as of counsel for Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. Service: 04/12/2018 by email. [513054] [18-1740] [Erik Olson] [Entered: 04/12/2018 08:31 PM] (2)
Apr 12, 2018 16 Docketing Statement for the Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. Service: 04/12/2018 by email. [513048] [18-1740] [Deanne Maynard] [Entered: 04/12/2018 07:28 PM] (4)
Apr 12, 2018 15 Entry of appearance for Sophia M. Brill as of counsel for Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. Service: 04/12/2018 by email. [513036] [18-1740] [Sophia Brill] [Entered: 04/12/2018 06:42 PM] (2)
Apr 12, 2018 14 Entry of appearance for Brian R. Matsui as of counsel for Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. Service: 04/12/2018 by email. [513035] [18-1740] [Brian Matsui] [Entered: 04/12/2018 06:40 PM] (2)
Apr 12, 2018 13 Entry of appearance for Robert S. Frank, Jr. as of counsel for Appellant Momenta Pharmaceuticals, Inc.. Service: 04/12/2018 by email. [513024] [18-1740] [Sophie Wang] [Entered: 04/12/2018 05:42 PM] (2)
Apr 12, 2018 12 Entry of appearance for Sophie F. Wang as of counsel for Appellant Momenta Pharmaceuticals, Inc.. Service: 04/12/2018 by email. [513000] [18-1740] [Sophie Wang] [Entered: 04/12/2018 04:50 PM] (2)
Apr 12, 2018 11 Entry of appearance for Robert A. Delafield II as of counsel for Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd.. Service: 04/12/2018 by email. [512992] [18-1740] [Robert Delafield] [Entered: 04/12/2018 04:34 PM] (2)
Apr 12, 2018 10 Entry of appearance for Natalie J. Morgan as of counsel for Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd.. Service: 04/12/2018 by email. [512978] [18-1740] [Natalie Morgan] [Entered: 04/12/2018 04:23 PM] (2)
Apr 12, 2018 9 Entry of appearance for Joshua Mack as of counsel for Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd.. Service: 04/12/2018 by email. [512973] [18-1740] [Joshua Mack] [Entered: 04/12/2018 04:10 PM] (2)
Apr 12, 2018 8 Entry of appearance for Douglas H. Carsten as of counsel for Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd.. Service: 04/12/2018 by email. [512967] [18-1740] [Douglas Carsten] [Entered: 04/12/2018 04:04 PM] (2)
Apr 12, 2018 7 Docketing Statement for the Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd.. Service: 04/12/2018 by email. [512963] [18-1740] [Michael Sommer] [Entered: 04/12/2018 03:55 PM] (3)
Apr 12, 2018 6 Certificate of Interest for the Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd.. Service: 04/12/2018 by email. [512960] [18-1740] [Michael Sommer] [Entered: 04/12/2018 03:52 PM] (0)
Apr 12, 2018 5 Entry of appearance for Michael S. Sommer as principal counsel for Appellees Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd.. Service: 04/12/2018 by email. [512959] [18-1740] [Michael Sommer] [Entered: 04/12/2018 03:51 PM] (2)
Apr 10, 2018 4 Certificate of Compliance with Fed. R. App. P. 10(b) [The Transcript of Proceedings] for Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. Service: 04/10/2018 by email. [512239] [18-1740] [Deanne Maynard] [Entered: 04/10/2018 05:39 PM] (3)
Apr 10, 2018 3 Certificate of Interest for the Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. Service: 04/10/2018 by email. [512238] [18-1740] [Deanne Maynard] [Entered: 04/10/2018 05:38 PM] (3)
Apr 10, 2018 2 Entry of appearance for Deanne E. Maynard as principal counsel for Appellants Momenta Pharmaceuticals, Inc. and Sandoz Inc.. Service: 04/10/2018 by email. [512233] [18-1740] [Deanne Maynard] [Entered: 04/10/2018 05:28 PM] (2)
Mar 29, 2018 1 Appeal docketed. Received: 03/28/2018. [509262]Entry of Appearance due 04/12/2018. Certificate of Interest is due on 04/12/2018. Docketing Statement due 04/12/2018. Appellant's brief is due 05/29/2018. [CMP] [Entered: 03/29/2018 03:37 PM] (173)
Menu